100 Vanguard Boulevard,
Malvern , PA, 19355
Malvern , PA, 19355
Summary
The fund seeks capital appreciation in the long term by investing in companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests in stocks of companies principally engaged in the development, production, or distribution of More
Link
Directors
Apr 11, 2024- F. Joseph Loughrey
- Mortimer J. Buckley
- David Thomas
- Scott C. Malpass
- Emerson U. Fullwood
- Tara Bunch
- Sarah Bloom Raskin
- Grant Reid
- Deanna Mulligan
- Peter F. Volanakis
- Lubos Pastor
- Mark Loughridge
- Andre F. Perold
Chief Compliance Officer
- Jacqueline Angell
Fund Manager(s)
- Jean Hynes
Price
- 52-Week High/Low
- $238.25 - $201.15
- Turnover
- 14.9%
- Expense Ratio
- 0.34%
Company Name |
Holding |
| Eli Lilly & Co | 8.21 % |
| UnitedHealth Group Inc | 7.49 % |
| AstraZeneca PLC | 5.64 % |
| Merck & Co Inc | 4.21 % |
| Novartis AG | 3.63 % |
| Novo Nordisk A/S | 3.44 % |
| Daiichi Sankyo Co Ltd | 3.08 % |
| Danaher Corp | 2.8 % |
| Pfizer Inc | 2.6 % |
| Thermo Fisher Scientific Inc | 2.55 % |
| More | 2.55 % |
Advisor
Documents
Performance
YTD
-
3 Year
-7.82%
5 Year
-4.35%
Best
60.49%
2000
Worst
-18.12%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 2.1% | -3.8% | -6.5% | -6.7% | -13.5% | 3.3% | 0.2% | 10.6% | -8.9% |
| Q2 | - | -2.9% | 4.3% | -5.6% | 18.3% | 16.2% | -1.2% | 3.1% | 6.5% | 5.4% |
| Q3 | - | - | -4.6% | -3.3% | -10.8% | -3% | -2.1% | 13.1% | 1% | 0.7% |
| Q4 | - | - | 3.1% | 9.8% | 4.9% | 4.6% | 8.6% | -11.4% | -0.5% | -5.9% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 0.7% | 2.7% | -1.3% | -4.8% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | -3% | -2% | -6% | 5% | 4% | 9% | 1% | 20% | 0% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| VGHCX | - | -3% | -2% | -6% | 5% | 4% | 9% | 1% | 20% | - |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | -3% | -2% | 15% | -21% | -13% | -20% | 7% | 0% | - |